Introduced
S. 483
Introduced in Senate · March 11, 2025February 6 (
legislative day
, February 5), 2025
Mr. King (for himself, Mr. Kaine, and Mr. Welch) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Responsibility in Drug Advertising Act of 2025”.